Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) is a biopharmaceutical company focused on the development and commercialization of innovative medicines that provide unique and meaningful advantages to people with renal disease and their healthcare providers. In September 2014, the U.S. Food and Drug Administration approved Keryx’s first medicine, AURYXIA® (ferric citrate) tablets. Patients have been and continue to be at the center of our 17-year corporate history. Keryx established its corporate headquarters in Boston to support the U.S. launch of AURYXIA. Joining Boston’s pioneering biotech community has given us the opportunity to bring together a seasoned talent pool of innovative minds and resources that will allow us to continue toward our goal of building a leading renal company. We are a rapidly growing company, with approximately 185 full-time employees across Boston and our field team.
View Top Employees from Keryx BiopharmaceuticalsWebsite | http://www.keryx.com |
Ticker | KERX |
Revenue | $60.6 million |
Funding | $46 million |
Employees | 151 (43 on RocketReach) |
Founded | 1998 |
Address | ONE MARINA PARK Dr, Boston, Massachusetts 02210, US |
Phone | (617) 466-3500 |
Fax | (617) 466-3501 |
Technologies |
JavaScript,
HTML,
PHP
+56 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Healthcare, Renal Disease, Science and Engineering, Pharmaceutical, Drug Manufacturing & Research, Health Care |
Web Rank | 5 Million |
Keywords | End Stage Renal Disease, Chronic Care |
Competitors | Aura Biosciences, Nephrogenex, THRASOS LIMITED, Tricida, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Keryx Biopharmaceuticals employee's phone or email?
The Keryx Biopharmaceuticals annual revenue was $60.6 million in 2024.
Greg Pitcher is the Corporate Account Director of Keryx Biopharmaceuticals.
43 people are employed at Keryx Biopharmaceuticals.
Keryx Biopharmaceuticals is based in Boston, Massachusetts.
The NAICS codes for Keryx Biopharmaceuticals are [3254, 54, 5417, 541, 325, 32541, 32].
The SIC codes for Keryx Biopharmaceuticals are [28, 283].